Quizo, Renato R.
HRN: 24-07-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/14/2023
12/20/2023
IV
2.25gm
Q6
Uti
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes